CN Patent

CN106459056A — 经取代的三唑苯二氮卓

Assigned to Concert Pharmaceuticals Inc · Expires 2017-02-22 · 9y expired

What this patent protects

本发明涉及式(I)的新颖经取代三唑苯二氮卓，其中每一变量如本文所定义，和其药学上可接受的盐。本发明还提供包含本发明化合物的组合物和此类组合物在治疗通过投与I‑BET762有益地治疗的疾病和病况的方法中的用途。

USPTO Abstract

本发明涉及式(I)的新颖经取代三唑苯二氮卓，其中每一变量如本文所定义，和其药学上可接受的盐。本发明还提供包含本发明化合物的组合物和此类组合物在治疗通过投与I‑BET762有益地治疗的疾病和病况的方法中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN106459056A
Jurisdiction
CN
Classification
—
Expires
2017-02-22
Drug substance claim
No
Drug product claim
No
Assignee
Concert Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.